Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-18 Sale | 2024-03-19 7:03 pm | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 4,879 | $30.6 | $149,297 | 99,405 (Direct) | View |
2023-03-21 Sale | 2023-03-23 7:56 pm | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 1,141 | $12.55 | $14,324 | 54,696 (Direct) | View |
2023-03-17 Sale | 2023-03-21 7:12 pm | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 740 | $12.94 | $9,573 | 55,837 (Direct) | View |
2023-03-16 Sale | 2023-03-17 6:15 pm | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 357 | $13.43 | $4,795 | 71,868 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-15 Exercise | 2024-03-19 7:03 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 26,490 | $0 | 99,405 (Direct) | View |
2024-03-07 Option Award | 2024-03-11 5:10 pm | N/A 2034-03-06 | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 79,579 | $0 | 79,579 (Direct) | View |
2023-03-15 Exercise | 2023-03-17 6:15 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 5,097 | $0 | 71,868 (Direct) | View |
2023-03-08 Option Award | 2023-03-10 7:26 pm | N/A 2033-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 80,708 | $0 | 80,708 (Direct) | View |
2022-03-09 Option Award | 2022-03-11 4:17 pm | N/A 2032-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 89,886 | $0 | 89,886 (Direct) | View |
2021-01-07 Option Award | 2021-01-08 4:57 pm | N/A 2031-01-06 | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 61,499 | $0 | 61,499 (Direct) | View |
Ownership | 2020-10-15 8:11 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 0 | $0 | 276,749 (Direct) | View |